Denovicon Therapeutics

Curated by Signal

Provider of AI-based technology for drug discovery

Overview

Denovicon Therapeutics provides AI-based technology for drug discovery. The company is focused on developing small-therapies for oncology and immuno-oncology targets with the help of a proprietary AI–molecular modeling (hybrid) algorithm.

Key facts

Founded: 2019
Headquarters: San Diego, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

Contact

Primary office: Sign up to view
Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Accu-Chek
Portfolio of Diabetes management products
Life Sciences TechnologyIndianapolis, United States
QT Medical
Developer of ECG devices and cardiac health monitoring tools
Life Sciences TechnologyTorrance, United States
Lexie
Provider of smart hearing aid solutions
Life Sciences TechnologyDekalb, United States

About Denovicon Therapeutics

What does Denovicon Therapeutics do?

Denovicon Therapeutics provides AI-based technology for drug discovery.

Where is Denovicon Therapeutics headquartered?

Denovicon Therapeutics is headquartered in San Diego, United States.

When was Denovicon Therapeutics founded?

Denovicon Therapeutics was founded in 2019.

Which sector is Denovicon Therapeutics in?

Denovicon Therapeutics operates in Life Sciences Technology.

Who are Denovicon Therapeutics's competitors?

Companies similar to Denovicon Therapeutics include Accu-Chek, QT Medical, and Lexie.